Default company panoramic image
249a36ba d5bf 4ef3 8bd9 2cb95471e5bb

Adient Medical

Adient Medical’s mission is the development of absorbable implantable medical devices with its first product an absorbable vascular filter.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Houston, TX, USA
  • Currency USD
  • Founded September 2010
  • Employees 2

Company Summary

Adient's first product is an absorbable vascular filter for the prevention of pulmonary embolism. Each year PE claims the lives of over 100,000 Americans — more than breast cancer and AIDS. Following the protection period, the filter absorbs via hydrolysis into CO2 and water, thereby obviating filter removal surgeries and avoiding long term complications. The prophylactic IVC filter market is growing 26% annual, expected $0.5 billion by 2015.


  • Default avatar
    Mitchell D. Eggers
    President and CEO

    CEO/GenVault ( Domain Associates-backed DNA dry-state archive co., 5yrs
    CEO/Genometrix: Motorolla-backed DNA chip co., 7 yrs
    Research Mgr/Southwest Orthopedic Group, 1yr
    Researcher/MIT Lincoln Lab, 5 yrs
    BS, MS, PhD Elec. Engr., Texas A&M
    MBA, Rice
    MD preclinical, Baylor College of Medicine
    30+ issued patents,
    $20M govt. rsch.,
    $30M venture capt.,
    $20M corp. part.,
    9 clinical trials Sub-I

  • Default avatar
    Michael Hogan
    Chief Scientific Officer

    CSO/GenVault, 10yrs
    VP Research/Inegenex, 2 yrs
    CSO/Genometrix, 4 yrs
    CSO/Triplex, antisense therapeutics, 8 yrs
    BS, Dartmouth
    PhD, Yale
    Postdoc, Stanford
    24 issued patents
    $10 govt. & industry sponsored rsch.


  • Default avatar
    Mintz Levin (corporate), Pillsbury Winthrop (IP)
    Default avatar
    Harrington, Carbone, & Allison, LLP

Previous Investors

  • Default avatar
    Founders, Raymond Kirk, Rob Tucci, Joseph Steele, Andrew Clark